fig1
![Autoimmune liver diseases, hepatocellular carcinoma, and recurrence of autoimmunity post-liver transplantation](https://image.oaes.cc/bf84ba24-660b-43da-8857-a8b6346099b2/4114.fig.1.jpg)
Figure 1. Prevention and treatment of AILD recurrence post LT. AZA: Azathioprine; IBD: inflammatory bowel disease; MMF: mycophenolate mofetil; OCA: obeticholic acid; UDCA: ursodeoxycholic acid.
Figure 1. Prevention and treatment of AILD recurrence post LT. AZA: Azathioprine; IBD: inflammatory bowel disease; MMF: mycophenolate mofetil; OCA: obeticholic acid; UDCA: ursodeoxycholic acid.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/